This ann. shows that they are funding Parkinsons research as well as proceeding with the MSA trial.
They don't say much, but this is interesting. Parkinsons is obviously a much larger concern in medicine
Ann: New Data Advance ATH434 as Neurodegeneration treatment, page-3
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $17.43K | 5.81M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 74 | 107941696 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 1179951 | 2 |
View Market Depth
| Last trade - 15.31pm 07/11/2024 (20 minute delay) ? |
| ATH (ASX) Chart |